Along with receiving a diagnosis of prostate cancer, comes new medical terminology that is likely unfamiliar to most men. One of the terms a man will hear is what is called a Gleason score. In 1966, a grading system for prostate cancer was developed by Dr. Donald Gleason. The Gleason score, still bearing his name today, is a system used to grade the aggressiveness of prostate cancer tissue.
Read MoreWhen diagnosing prostate cancer, a Gleason score is used to determine how aggressive the cancer is. Before understanding what the Gleason score means, one should know how a Urologist comes up with a Gleason score in the first place. To identify the Gleason score, a Urologist will do a prostate biopsy which involves collecting prostate tissue samples. These prostate tissue samples are then sent to a lab to be analyzed by a pathologist. The pathologist will determine the Gleason score which is made up of two numbers: a primary grade and a secondary grade.
Read MoreThe Gleason score is a system using to grade prostate cancer tissue which is dependent upon how it looks when analyzed under a microscope. The Gleason score ranges from two to ten and is an indicator of how likely it is that the cancer will spread. It also provides the doctor with the necessary information needed to select the most optimal treatment plan for the patient. Similar to staging prostate cancer, grade are given to each prostate cancer case to determine the severity of the disease. A urologist will assign a grade to the prostate cancer after the patient has undergone a prostate biopsy. The tissue samples are sent to a laboratory to be analyzed by a pathologist.
Read MoreThe grading system for prostate cancer is used to help assess the prognosis of prostate cancer. It also provides the doctor with the necessary information needed to select the most optimal treatment plan for the patient. Similar to staging prostate cancer, grade are given to each prostate cancer case to determine the severity of the disease. A urologist will assign a grade to the prostate cancer after the patient has undergone a prostate biopsy. The tissue samples are sent to a laboratory to be analyzed by a pathologist.
Read More
